Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis
Open Access
- 1 November 2013
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 55 (2) , 334-342
Abstract
The efficacy and toxicity of five-fraction CyberKnife radiotherapy were evaluated in patients with large brain metastases in critical areas. A total of 85 metastases in 78 patients, including tumors >30 cm3 (4 cm in diameter) were treated with five-fraction CyberKnife radiotherapy with a median marginal dose of 31 Gy at a median prescribed isodose of 58%. Changes in the neurological manifestations, local tumor control, and adverse effects were investigated after treatment. The surrounding brain volumes circumscribed with 28.8 Gy (single dose equivalent to 14 Gy: V14) were measured to evaluate the risk of radiation necrosis. Neurological manifestations, such as motor weakness, visual disturbances and aphasia improved in 28 of 55 patients (50.9%). Local tumor control was obtained in 79 of 85 metastases (92.9%) during a median follow-up of eight months. Symptomatic edema occurred in 10 patients, and two of them (2.6%) required surgical resection because of radiation necrosis. The V14 of these patients was 3.0–19.7 cm3. There were 16 lesions with a V14 of ≥7.0 cm3, and two of these lesions developed extensive brain edema due to radiation necrosis. None of the patients with a V14 of 3 exhibited edema requiring surgical intervention. We therefore conclude that a high rate of local tumor control and low rates of complications can be obtained after five-fraction CyberKnife radiotherapy for large metastases in critical areas. The V14 of the surrounding brain is therefore a useful indicator for the risk of radiation necrosis in patients with large metastases.Keywords
This publication has 26 references indexed in Scilit:
- Single-fraction radiosurgery of benign cavernous sinus meningiomasJournal of Neurosurgery, 2013
- Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14)Journal of Radiation Research, 2013
- Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single dosesJournal of Radiation Research, 2012
- Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimetersRadiation Oncology, 2012
- Compatibility of the Linear-Quadratic Formalism and Biologically Effective Dose Concept to High-Dose-Per-Fraction Irradiation in a Murine TumorInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Outcomes and Prognostic Factors for Patients With Brainstem Metastases Undergoing Stereotactic RadiosurgeryNeurosurgery, 2011
- Therapeutic Effect of Linac-based Stereotactic Radiotherapy with a Micro-multileaf Collimator for the Treatment of Patients with Brain Metastases from Lung CancerJapanese Journal of Clinical Oncology, 2009
- The Role of Cyberknife Radiosurgery/Radiotherapy for Brain Metastases of Multiple or Large-Size Tumorsmin - Minimally Invasive Neurosurgery, 2006
- Use of Posteroventral Pallidotomy for Treatment of Parkinson’s Disease: Is Pallidotomy Still an Experimental Procedure?Stereotactic and Functional Neurosurgery, 1998
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997